Thu. 2 May 2024, 3:44am ET
Benzinga
News
PDUFA Target Action Date of June 26, 2024
Eight posters including two oral presentations support potential of ensifentrine, an investigational, first-in-class, selective, dual inhibitor of PDE3 and PDE4